PWA
DXCM icon

Provenance Wealth Advisors’s DexCom DXCM Stock Holding History

Provenance Wealth Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-30
Closed -$2.05K – 458
2025
Q1 		$2.05K Hold
30
– – ﹤0.01% 402
2024
Q4 		$2.33K Hold
30
– – ﹤0.01% 413
2024
Q3 		$2.01K Hold
30
– – ﹤0.01% 461
2024
Q2 		$3.4K Hold
30
– – ﹤0.01% 347
2024
Q1 		$4.16K Sell
30
-16
-35% -$2.01K ﹤0.01% 362
2023
Q4 		$5.71K Buy
46
+16
+53% +$1.64K ﹤0.01% 355
2023
Q3 		$2.8K Buy
+30
New +$3.38K ﹤0.01% 294

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Provenance Wealth Advisors's DXCM Position: Q2 2025 in Review

Provenance Wealth Advisors sold out of DexCom (DXCM) in Q2 2025, closing a stake of 30 shares — an estimated $2.05K sold.

Provenance Wealth Advisors first reported a position in DXCM in Q3 2023 and held it in 7 quarters. The position peaked at $5.71K in Q4 2023. 939 funds tracked by Wall St. Rank hold DXCM as of Q2 2025.

  • Provenance Wealth Advisors reported no remaining DexCom position as of Q2 2025 after selling out during the quarter.
  • Provenance Wealth Advisors sold 30 DexCom shares in Q2 2025, an estimated $2.05K.
  • Provenance Wealth Advisors first reported a position in DexCom in Q3 2023 and held it in 7 quarters.
  • Provenance Wealth Advisors's DexCom position peaked at $5.71K in Q4 2023.
  • 939 funds tracked by Wall St. Rank held DexCom as of Q2 2025.

Based on Provenance Wealth Advisors's 13F filing for Q2 2025, filed 15 Aug 2025.